Wirk, Baldeep, and Jin Lim. “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”. Journal of Hematology 14, no. 3 (January 1, 2025): 146–151. Accessed January 11, 2026. https://jh.elmerpub.com/jh/article/view/2046.